New drug combo safety checked in healthy volunteers
NCT ID NCT02479204
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage study looked at whether a new drug called ACT-334441 is safe when taken with two common heart medications (diltiazem and atenolol). Ten healthy volunteers were enrolled to check heart rate, blood pressure, and how the drugs interact. The study was terminated early, so results are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ACT-334441
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BIOTRIAL
Rennes, CS 34246, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive tracer reveals the Body's journey of an experimental drug
- Can music lessons rewire Teens' social media habits?
- Can a Finger-Prick replace the lab draw? a device puts accuracy to the test
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- Sound waves as medicine: ultrasound may tame inflammation without drugs
- Broader pneumonia shield: new vaccine tested in children